Global Stock News

A 219.84% Potential Upside Awaits Investors

A 219.84% Potential Upside Awaits Investors

Niagen Bioscience, Inc. (NAGE), a key player in the biotechnology sector, has been capturing investor attention due to its impressive growth potential. As a company focused on the development of healthy aging products, Niagen stands at the intersection of science and consumer health, offering a compelling opportunity for investors seeking exposure to the burgeoning healthcare market.

#### Company Overview

Headquartered in Los Angeles, California, Niagen Bioscience operates through three primary segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The company is renowned for its flagship ingredient, nicotinamide riboside, marketed under the NIAGEN brand. This ingredient plays a crucial role in…

Source link

Share this article

Scroll to Top